Chinese Expent Consensus Statement on Multi-disciplinary Perioperative Airway Management (2016 Version)_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

Corresponding?author：

Keywords：

圍手術期氣道管理; 多學科; 專家共識

DOI：

10.7507/1007-4848.20160156

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： . Chinese Expent Consensus Statement on Multi-disciplinary Perioperative Airway Management (2016 Version). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2016, 23(7): 641-645. doi: 10.7507/1007-4848.20160156 Copy

1.	支修益. 胸外科圍手術期氣道管理專家共識(2012年版). 中國胸心血管外科臨床雜志, 2013, 20(3) :251-255.
2.	Mei J, Liu L, Tang M, et al. Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period. J Thorac Dis, 2014, 6(9) :1200-1208. doi:10.3978/j.issn.2072-1439.2014.07.07.
3.	Gao K, Yu PM, Su JH, et al.Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery:A study for 342 cases. Thorac Cancer, 2015, 6(4) :443-449.
4.	Taylor MD, LaPar DJ, Isbell JM, et al. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer. J Thorac Cardiovasc Surg, 2014, 147(2) :738-744.
5.	Mehran R, Deslauriers J, 主編. 陳克能, 編譯. 普通胸外科圍手術期治療手冊. 北京:人民衛生出版社, 2007.9.
6.	于布為, 田鳴, 高學, 等. 困難氣道管理指南. 臨床麻醉學雜志, 2013, 29:93-98.
7.	歐陽葆怡, 吳新民. 肌肉松弛藥合理應用的專家共識 (2013) . 臨床麻醉學雜志, 2013, 29(7) :712-715.
8.	中國加速康復外科專家組. 中國加速康復外科圍手術期管理專家共識. 中華外科雜志, 2016, 54(6) :413-418.
9.	中華醫學會麻醉學分會. 中國麻醉學指南與專家共識. 北京:人民衛生出版社, 2014.257-264.
10.	國家衛生和計劃生育委員會. 抗菌藥物臨床應用指導原則(2015年版). 中國醫藥生物技術, 2015, 10(5) :477.
11.	李莉, 金海浩, 黃清杰. 從9例藥品不良事件探討氨溴索聯合地塞米松霧化吸入給藥的合理性. 中國新藥與臨床雜志, 2014, 33(2) :919-921.
12.	B?lükbas S, Eberlein M, Eckhoff J, et al. Short-term effects of inhala-tive tiotropium/formoterol/budenoside versus tiotropium/formo-terol in patients with newly diagnosed chronic obstructive pulmo-nary disease requiring surgery for lung cancer:a prospective rando-mized trial. Euro J Cardio-thoracic Surg, 2011, 39(6) :995-1000.
13.	Gómez Sebastián G, Güell Rous R, González Valencia A, et al. Impact of a rescue program on the operability of patients with bronchogenic carcinoma and chronic obstructive pulmonary disease. Arch Bron-coneumol, 2007, 43(5) :262-266.
14.	Ju NY, Gao H, Huang W, et al. Therapeutic effect of inhaled bude-sonide (Pulmicort^? Turbuhaler) on the inflammatory response to one-lung ventilation. Anaesthesia, 2014, 69(1) :14-23.
15.	溫開蘭, 楊孟昌, 蔣蓉, 等. 布地奈德聯合利多卡因霧化吸入降低雙腔氣管導管插管對咽喉部相關并發癥的作用. 昆明醫科大學學報, 2015, 36(3) :105-109.
16.	劉玉, 張梅, 袁耒, 等. 伴中、重度慢性阻塞性肺疾病行開胸手術患者圍手術期氣道管理藥物應用評價. 中國胸心血管外科臨床雜志, 2015, 22(12) :1104-1108.
17.	Li W, Zhao Y, Sun Z, et al. Lung protective effects of budesonide nebulization during perioperative period of thoracolumbar fusion. J Thorac Dis, 2014, 6(12) :1800.
18.	車國衛,支修益. 肺癌合并慢性阻塞性肺疾病患者圍手術期氣道管理現狀.中國肺癌雜志, 2014, 17(12) :884-888.

1. 支修益. 胸外科圍手術期氣道管理專家共識(2012年版). 中國胸心血管外科臨床雜志, 2013, 20(3) :251-255.
2. Mei J, Liu L, Tang M, et al. Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period. J Thorac Dis, 2014, 6(9) :1200-1208. doi:10.3978/j.issn.2072-1439.2014.07.07.
3. Gao K, Yu PM, Su JH, et al.Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery:A study for 342 cases. Thorac Cancer, 2015, 6(4) :443-449.
4. Taylor MD, LaPar DJ, Isbell JM, et al. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer. J Thorac Cardiovasc Surg, 2014, 147(2) :738-744.
5. Mehran R, Deslauriers J, 主編. 陳克能, 編譯. 普通胸外科圍手術期治療手冊. 北京:人民衛生出版社, 2007.9.
6. 于布為, 田鳴, 高學, 等. 困難氣道管理指南. 臨床麻醉學雜志, 2013, 29:93-98.
7. 歐陽葆怡, 吳新民. 肌肉松弛藥合理應用的專家共識 (2013) . 臨床麻醉學雜志, 2013, 29(7) :712-715.
8. 中國加速康復外科專家組. 中國加速康復外科圍手術期管理專家共識. 中華外科雜志, 2016, 54(6) :413-418.
9. 中華醫學會麻醉學分會. 中國麻醉學指南與專家共識. 北京:人民衛生出版社, 2014.257-264.
10. 國家衛生和計劃生育委員會. 抗菌藥物臨床應用指導原則(2015年版). 中國醫藥生物技術, 2015, 10(5) :477.
11. 李莉, 金海浩, 黃清杰. 從9例藥品不良事件探討氨溴索聯合地塞米松霧化吸入給藥的合理性. 中國新藥與臨床雜志, 2014, 33(2) :919-921.
12. B?lükbas S, Eberlein M, Eckhoff J, et al. Short-term effects of inhala-tive tiotropium/formoterol/budenoside versus tiotropium/formo-terol in patients with newly diagnosed chronic obstructive pulmo-nary disease requiring surgery for lung cancer:a prospective rando-mized trial. Euro J Cardio-thoracic Surg, 2011, 39(6) :995-1000.
13. Gómez Sebastián G, Güell Rous R, González Valencia A, et al. Impact of a rescue program on the operability of patients with bronchogenic carcinoma and chronic obstructive pulmonary disease. Arch Bron-coneumol, 2007, 43(5) :262-266.
14. Ju NY, Gao H, Huang W, et al. Therapeutic effect of inhaled bude-sonide (Pulmicort^? Turbuhaler) on the inflammatory response to one-lung ventilation. Anaesthesia, 2014, 69(1) :14-23.
15. 溫開蘭, 楊孟昌, 蔣蓉, 等. 布地奈德聯合利多卡因霧化吸入降低雙腔氣管導管插管對咽喉部相關并發癥的作用. 昆明醫科大學學報, 2015, 36(3) :105-109.
16. 劉玉, 張梅, 袁耒, 等. 伴中、重度慢性阻塞性肺疾病行開胸手術患者圍手術期氣道管理藥物應用評價. 中國胸心血管外科臨床雜志, 2015, 22(12) :1104-1108.
17. Li W, Zhao Y, Sun Z, et al. Lung protective effects of budesonide nebulization during perioperative period of thoracolumbar fusion. J Thorac Dis, 2014, 6(12) :1800.
18. 車國衛,支修益. 肺癌合并慢性阻塞性肺疾病患者圍手術期氣道管理現狀.中國肺癌雜志, 2014, 17(12) :884-888.

Next Article
Self-management of Anticoagulation Monitoring for Patients Following Mechanical Heart Valve Replacement: A non-randomized Controlled Trial

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Chinese Expent Consensus Statement on Multi-disciplinary Perioperative Airway Management (2016 Version)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content